Anteris Technologies (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Ltd, a structural heart company, designs, develops, and commercializes medical devices. The company manufactures and sells ADAPT, a regenerative tissue product. Its lead product is the DurAVRTM, a transcatheter heart valve for the treatment of aortic stenosis. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$469.68 million
• P/E Ratio: N/A
• Dividend Yield: 6.45%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:AVR
• CIK: N/A
• Web: www.anteristech.com
• Phone: 61 1300 550 310
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($5.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$87.90 million
• Net Margins: -2,260.86%
• Pretax Margin: N/A
• Return on Equity: -512.81%
• Return on Assets: -195.55%

Debt

• Debt-to-Equity Ratio: 48.65
• Current Ratio: 0.96
• Quick Ratio: 4.07

Sales & Book Value

• Annual Sales: A$3.89 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.25 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 21,140,000
• Free Float: N/A
• Market Cap: A$469.68 million
• Optionable: Not Optionable
• Beta: 0.71